UC Law dean to headline “Dangerous Dames” event

Dean Verna Williams, Nippert Professor of Law, will be the keynote speaker at Dangerous Dames of Dayton 2022, the signature event of the League of Women Voters of the Greater Dayton area.

Verna L. Williams, JD
Dean
LAW-College of Law

Dean Verna Williams

Dean Williams will discuss voting and its importance for everyone. The event will be held at 5:30 pm, Tues., March 8, 2022 at the NCR Country Club in Kettering, OH Tickets are $100 and can be purchased online at   lwvdayton.org/dangerous-dames-2022.

This year’s event will celebrate the accomplishments of local women who have made impactful contribution. Inductees include Carol Graff, community volunteer; Reverend Dawn Martin, associate minister at Omega Baptist Church and founder of The Risen Empowerment Resource Center, Inc., Diva by Design Ministries and G.E.M.S, Girls Empowered and Mentored to Success; and, Reverend Vanessa Ward, president, the Omega Community Development Corporation.

The term “dangerous dames” was devised in honor of the Dayton (OH) suffragists who marched and protested through Dayton streets and were deemed “dangerous to polite society.” These women went on to become the founders of Dayton’s League of Women Voters in 1920. For over one hundred years, the Dayton League has been at the forefront of voters’ rights and human rights, and is a strong proponent of diversity, equity, and inclusion.

Photo credits

Header: istockphoto.com

Dean Williams photo: Andrew Higley, UC Photography

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.